P3 Health Partners Inc. - Class A Common Stock (PIII)
0.1857
+0.0026 (1.42%)
P3 Health Partners Inc. is a healthcare organization that focuses on enhancing the quality of care for patients, particularly those within government-sponsored healthcare programs
The company employs a value-based approach to healthcare management, working closely with physicians and healthcare providers to optimize patient outcomes while reducing overall costs. P3 Health Partners leverages innovative technologies and data analytics to improve care coordination, streamline services, and engage patients in their own health journeys, ensuring that individuals receive personalized attention and support throughout their healthcare experiences.
P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that it will participate in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, Massachusetts.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered, physician-led population health management company, is targeting profitability in 2025, with initial revenue guidance for the year of $1.350 billion to $1.500 billion and Adjusted EBITDA of negative ($35) million to $5 million.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced it will participate at the upcoming J.P. Morgan Healthcare Conference in San Francisco, California.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the Noble Capital Markets 20th Annual Emerging Growth Equity Conference, on Tuesday, December 3, 2024, in Boca Raton, FL, at 3:30 pm Eastern Time.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced the Company will participate in the following upcoming investor conferences:
P3 Health Partners (NASDAQPIII) is revolutionizing healthcare by focusing on improving patient outcomes through value-based care. The company will be presenting alongside world-class headliners such as Zack Kass, former Head of Go-To-Market at OpenAI where ChatGPT was created, and “Shark Tank” stars Kevin O’Leary, Robert Herjavec, and Daymond John.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the third quarter ended September 30, 2024.
P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for third quarter 2024 and file its Quarterly Report on Form 10-Q on Tuesday, November 12, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that management is scheduled to present at the LD Micro Main Event XVII Conference on Wednesday, October 30, 2024, in Los Angeles, CA, at 2:30 pm Eastern Time.
P3 Health Partners Inc. ("P3") (NASDAQPIII), a patient-centered and physician-led population health management company, announced today that Leif Pedersen, an experienced finance, operational and value-based care executive, will join the company as chief financial officer (CFO) effective October 1, 2024. Pedersen succeeds Atul Kavthekar, who will continue as CFO until September 30, 2024, after which he will serve as a Strategic Advisor to the company.
P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company will participate at the following upcoming investor conferences:
P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced its financial results for the second quarter ended June 30, 2024.
P3 Health Partners Inc. (“P3”) (NASDAQPIII), a patient-centered and physician-led population health management company, today announced that the Company plans to release its financial results for second quarter 2024 and file its Quarterly Report on Form 10-Q on Wednesday, August 7, 2024. In connection with the release, management will host a conference call to discuss the financial results at 1:30pm PT/ 4:30pm ET the same day.
Innovaccer Inc., a leading healthcare AI company, announced a new strategic partnership with P3 Health Partners, (NASDAQPIII), a patient-centered, physician-led population health management company revolutionizing care delivery for Medicare patients. This partnership marks a significant milestone in advancing value-based care initiatives aimed at improving patient outcomes, optimizing costs, and enhancing the patient and clinician experience.
